| Code | Name | Deposits | Targets | Ligand Type |
|---|---|---|---|---|
| 3D1 | (2r,3s,5r)-5-(6-amino-9h-purin-9-yl)-tetrahydro-2-(hydr oxymethyl)furan-3-ol | 1 | 1 | biological |
| 3HB | 1 | 1 | biological | |
| 2NV | 3,6,9,12,15-pentaoxaoctadecan-17-amine | 1 | 1 | crystallization |
| 30N | (3r,5s,9r)-1-[(2r,3s,4r,5r)-5-(6-amino-9h-purin-9-yl)-4-hydroxy-3-(phosphonooxy)tetrahydrofuran-2-yl]-3,5,9-tr ihydroxy-8,8-dimethyl-10,14-dioxo-2,4,6-trioxa-11,15-di aza-3,5-diphosphaheptadecane-17-sulfinic acid 3,5-dioxi de (non-preferred name) | 1 | 1 | biological |
| 3GR | glyceraldehyde | 1 | 1 | other |
| 13P | 1,3-dihydroxyacetonephosphate | 1 | 1 | biological |
| 0J9 | 1-tert-butyl-3-(naphthalen-1-yl)-1h-pyrazolo[3,4-d]pyri midin-4-amine | 1 | 1 | crystallization |
| 0TO | 1 | 1 | crystallization | |
| 16G | n-acetyl-d-glucosamine-6-phosphate | 1 | 1 | biological |
| 0JN | 1-tert-butyl-3-(naphthalen-1-ylmethyl)-1h-pyrazolo[3,4-d]pyrimidin-4-amine | 1 | 1 | crystallization |
| 131 | 1 | 1 | biological | |
| 0RV | (2s)-2-[(1s,2r)-1-carboxy-2-hydroxypropyl]-4-{[(3s,5s)-5-(dimethylcarbamoyl)pyrrolidin-3-yl]sulfanyl}-3-methyl-2h-pyrrole-5-carboxylic acid | 1 | 1 | biological |
| 176 | 1 | 1 | crystallization | |
| 178 | 1 | 1 | biological | |
| 178 | 1 | 1 | crystallization | |
| 13P | 1,3-dihydroxyacetonephosphate | 1 | 1 | other |
| 1X6 | o-[(2e)-3-aminoprop-2-enoyl]-l-serine | 1 | 1 | biological |
| 221 | 1 | 1 | crystallization | |
| 225 | 1 | 1 | biological | |
| 537 | 2,6-dihydroanthra/1,9-cd/pyrazol-6-one | 1 | 1 | crystallization |